SLV-154 Treatment Trial
Phase 1
70
about 2 years
18+
9 sites in CA, MO, NJ +3
What this study is about
This trial is testing SLV-154 in people with advanced cancers. The goal is to see if SLV-154 is safe and how it works in the body, as well as whether it has any effect on cancer cells.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take SLV-154
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: MTD and/or RDR
Secondary: Duration of Response (DOR), Immunogenicity, Objective Response Rate (ORR), Overall survival (OS), Progression-free survival (PFS), SLV-154 Pharmacokinetics, Time to Response (TTR), Time to treatment failure (TTF)
Oncology